 | | | | A unit of Abbott Laboratories is recalling two COVID-19 test kits as they can potentially issue false positive results, the U.S. Food and Drug Administration (FDA) said on Thursday. | | | | | | White House press secretary Jen Psaki said on Thursday that U.S. President Joe Biden has yet to make a final decision on who to nominate to lead the Food and Drug administration. | | | | | | The U.S. government has donated 3.6 million doses of the Pfizer Inc/BioNTech SE , COVID-19 vaccine to Nigeria, a local television station said, adding that the shipment arrived in the country's capital Abuja on Thursday. | | | | | | The State Department on Thursday defended its handling of so-called Havana Syndrome health complaints, after a bipartisan group of U.S. senators said they were concerned the unexplained ailments were not being taken seriously enough. | | | | | | Nigeria has received 501,600 doses of AstraZeneca's COVID-19 vaccine from the French government through the COVAX vaccine-sharing facility, a senior health official said on Thursday. | | | | | | A panel of expert advisers to the U.S. Food and Drug Administration voted on Thursday to recommend booster shots of Moderna Inc's COVID-19 vaccine for Americans aged 65 and older and those at high risk of severe illness. | | | | | | President Joe Biden told visiting Kenyan President Uhuru Kenyatta on Thursday that the United States will make a one-time donation of more than 17 million doses of the Johnson & Johnson vaccine to the African Union, the White House said. | | | | | | A panel of expert advisers to the U.S. Food and Drug Administration unanimously voted on Thursday to recommend booster shots of Moderna Inc's COVID-19 vaccine for Americans aged 65 and older and those at high risk of severe illness or occupational exposure to the virus. | | | | | | The European Union and South Africa are in "intense talks" on how to increase the availability of vaccines to developing countries, potentially breaking a year-long global deadlock on the topic, an EU official said on Thursday. | | | | | | A panel of outside advisers to the U.S. health regulator will meet late next month to discuss whether to authorize Merck & Co's experimental COVID-19 antiviral drug, the agency said on Thursday. | | | | | |
